Center for Drug Evaluation and Safety

The University of Florida Center for Drug Evaluation and Safety, or CoDES, unites researchers interested in using big data to evaluate drugs and the safety of medications in real-world populations. More than 20 drug safety researchers representing four of the six academic colleges at UF Health are members of the center. With backgrounds in epidemiology, health economics and health services research, the multidisciplinary group develops new methods and analytical tools to enhance drug evaluation and regulatory science.

Center for Integrative Cardiovascular and Metabolic Disease

The University of Florida Center for Integrative Cardiovascular and Metabolic Disease supports an emerging group of more than 25 UF faculty researching cardio-metabolic diseases, including Type 2 diabetes, obesity, chronic kidney disease, stroke and atherosclerosis. The center will enrich research collaborations in publishing high-impact manuscripts and securing grant funding.

Center for Natural Products, Drug Discovery and Development

The University of Florida Center for Natural Products, Drug Discovery and Development (CNPD3) fosters early-stage drug discovery by providing infrastructure, chemical libraries and expertise to screen for disease-relevant targets and molecules that modulate target activity. A compound identified during the discovery program will serve as the starting point for development campaigns

Center for Pharmacogenomics and Precision Medicine

The Center for Pharmacogenomics and Precision Medicine is part of the College of Pharmacy at the University of Florida.  We are one of the leading educational institutions in pharmacogenomics research and training of future scientists.  Our collaboration in pharmacogenomics research with other disciplines such as medicine, dentistry and biological sciences at the University of Florida, ensures innovation in this cutting edge science.

Center for Pharmacometrics and Systems Pharmacology

Pharmacometrics & System Pharmacology is the combination of two interrelated disciplines that seek to quantify disease, drug and clinical trial characteristics in individual and population levels. Using systems biology approaches, researchers study drug activities, targets and clinical effects to support and advance translational research, which improves the process of bringing new drugs to market for improved patient therapies, including personalized medicines.

Research Core

UF Translational Drug Development Core

Led by faculty in the UF College of Pharmacy, the CTSI Translational Drug Development Core provides services and expertise in bioanalytical drug metabolism and preclinical pharmacokinetics in order to help faculty bridge this gap.